Association of Aldosterone, Renin, and Aldosterone to Renin Ratio with Metabolic Profile in Primary Aldosteronism
DOI: https://doi.org/10.2147/dmso.s457243
2024-05-19
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Minmin Han, 1, 2, &ast Xiaoming Cao, 3, &ast Jian Zhang, 1, 2 Xifeng Yang, 1, 2 Yi Zhang, 4, 5 Yunfeng Liu 1, 2 1 Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, 030000, People's Republic of China; 2 First Clinical Medical College, Shanxi Medical University, Taiyuan, 030000, People's Republic of China; 3 Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, 030000, People's Republic of China; 4 Department of Pharmacology, Shanxi Medical University, Taiyuan, 030000, People's Republic of China; 5 Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan, 030000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yunfeng Liu, Department of Endocrinology, First Hospital of Shanxi Medical University, No. 85, Jiefang Nan Road, Taiyuan, 030000, People's Republic of China, Tel +86-18703416196, Fax +86-351-4639756, Email Yi Zhang, Department of Pharmacology, Shanxi Medical University, No. 56, Xinjian Nan Road, Taiyuan, 030000, People's Republic of China, Tel +86-18835102847, Fax +86-351-4135971, Email Purpose: This study aimed to investigate the glycometabolism, fat mass, and lean mass in primary aldosteronism (PA) during disease progression. Patients and Methods: Patients diagnosed with PA and healthy controls (HCs) were enrolled. A flash glucose monitoring system (FGMS) and dual-energy X-ray absorptiometry (DEXA) were used to measure glucose variability and glucose target rate along with fat mass and lean mass. Comparative analysis of FGMS- or DEXA-derived parameters along with correlation analyses between these parameters and PA progression were performed. Results: Increased glucose variability and poor glucose target rate, along with an increased proportion of truncal fat mass, and decreased proportion of appendicular lean mass, were identified in PA group compared to those in HCs. Plasma aldosterone concentration was positively correlated with glucose variability and poor glucose target rate. Plasma renin concentration was positively correlated with the proportion of truncal fat mass and lean mass, and negatively correlated with the proportion of appendicular fat mass. Aldosterone-to-renin ratio was negatively correlated with the proportion of truncal fat mass and lean mass, and positively correlated with the proportion of appendicular fat mass. Conclusion: Patients with PA presented significant differences in glycometabolism, fat mass, and lean mass compared with HCs, and these alterations correlated with PA progression. Keywords: glucose variability, fat mass, lean mass, aldosterone, renin, ARR, correlation analysis Clinical and experimental models have conclusively documented the central and indispensable role of the renin-angiotensin-aldosterone system (RAAS) in maintaining homeostasis of intravascular volume and electrolytes. In the recent few years, there has been a growing awareness of the exponentially increasing occurrence of renin-dependent or renin-independent aldosteronism, wherein primary aldosteronism (PA) is one of the most investigated targets of researchers. Autonomous aldosterone secretion is the core feature of PA, accompanied by suppressed secretion of renin and angiotensin. 1 Patients with PA are typically associated with hypertension, hypokalaemia, and metabolic alkalosis, followed by an increased risk of cardiovascular disease (CVD), atrial fibrillation, and mortality. Owing to the higher occurrence of cardiovascular events in patients with PA than in those with essential hypertension, there is now a growing emphasis on the pathogenesis underlying the development of CVD. 2,3 A significant body of evidence gathered from studies indicates the extensive prevalence of impaired glycometabolism, obesity, and muscle loss in patients with PA, 4–6 all of which are widely accepted risk factors involved in the pathogenesis of CVD. 7 Several groups have also reported that aldosterone levels are correlated with plasma glucose levels, islets β-cell function, and visceral fat mass. 8,9 Further studies followed, showing a correlation between renin or aldosterone-to-renin ratio (ARR) and diabetes prevalence, glucose metabolism indices, or visceral fat mass. 10,11 Collectively, the relationship between PA and distribution of body fat mass (FM), lean mass (LM) is relatively unexplored area. There is growing support for the notion that regional FM and LM are related to distinct effects on metaboli -Abstract Truncated-
endocrinology & metabolism